Prospective Study of Hearing Loss and Type I Diabetes

Not Applicable

Recruiting

• Conditions: Hearing Loss; Diabetes Mellitus; Metabolic and Endocrine - Diabetes; Ear - Other ear disorders

• Registration Number: ACTRN12615000486527
• Lead Sponsor: Mohammed Al-Sofiani

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Inclusion Criteria:
1)Adult (aged 20-60 years-old) at start of screening.
2)Type I DM.

Exclusion Criteria

Exclusion Criteria:
1)History of otitis media.
2)History of Meniere's disease
3)Noise exposure (Occupational, recreational, or military)
4)Use of toxic drugs:
a)High dose aspirin (6-8 g/day)
b)Antibiotics (e.g. aminoglycoside, erythromycin, tetracycline)
c)Loop diuretic
d)Cisplatin
e)5-Fluorouracil
f)Bleomycin
5)Cocaine abuse.
6)Congenital diseases associated with hearing impairment such as Arnold Chiari malformation.

Study & Design

• Study Type: Observational
• Study Design: Not specified